Although syphilis has been recognized as a clinical entity for centuries, knowledge of the biology and pathogenicity of the etiologic agent, Treponema pallidum, remains limited because of the inability to continuously culture the spirochete in vitro (14) . Since cultivation of T. pallidum in experimentally infected rabbits provides only limited quantities of organisms, investigators have made use of recombinant DNA and monoclonal antibody technologies to facilitate the study of this bacterium. Genomic libraries of T. pallidum Nichols DNA have been constructed, and the protein products expressed from a number of cloned genes have been identified and characterized (1, 26, 41, 50) . Most of these proteins were selected on the basis of reactivity with syphilitic sera from infected humans or experimentally infected rabbits or with monoclonal antibodies directed against T. pallidum. Since there is currently no vaccine for syphilis, antigenic proteins, particularly membrane proteins, continue to be a focus for investigation.
While T. pallidum evokes strong humoral and cellular responses in infected humans and rabbits, studies have shown that the outer membrane appears, paradoxically, to have limited antigenic reactivity in the intact organism and to contain relatively few protein molecules (6, 27, 31, 34, 42, 51) . However, the fragility of the outer membrane may allow the exposure of underlying antigens (e.g., periplasmic flagella) to specific antibodies. Although separation of the inner and outer membranes of T. pallidum has not yet been achieved, simple cell fractionation studies have shown that a number of proteins are associated with the whole-membrane fraction (40) . Radolf et al. (33) and Cunningham et al. (11) have used phase partitioning with the nonionic detergent Triton X-114 to identify and characterize pathogen-specific integral membrane proteins from whole T. pallidum cells. Investigations with treponemes incubated in the presence of 3H-labeled fatty acids have shown that many of these highly * Corresponding author.
immunogenic detergent-phase proteins (DPPs) are lipoproteins (8, 38) . Additionally, Baker-Zander et al. have demonstrated that certain of these lipoprotein antigens stimulate a proliferative response in splenic lymphocytes obtained from syphilitic rabbits (2) . Since the cellular immune response may be of particular importance in the clearance of T. pallidum from early lesions and in the control of infection (21, 37) , the identification of treponemal lipoproteins has generated considerable interest. The genes encoding T. pallidum lipoproteins of 47, 42, 34 , and 15 kDa have been cloned, and the recombinant proteins have been purified and characterized in further detail (9, 19, 32, 38, 46) .
To date, all reported studies of the cloning of T. pallidum DNA and the majority of studies dealing with the pathogenesis of syphilis have used the Nichols strain of T. pallidum. This strain, which was isolated in 1912 from the cerebrospinal fluid of a patient with recurrent neurosyphilis, has been maintained by successive passage in laboratory rabbits (49) . Although the Nichols strain remains virulent for humans (15) , it is not known how representative it is of current clinical isolates of T. pallidum. We have constructed a cosmid library of genomic DNA from a relatively recent (1977) clinical isolate of T. pallidum, designated street strain 14 (44) , and have identified a clone expressing a treponemal lipoprotein of approximately 35.5 kDa. The native counterpart of this protein partitions into the detergent phase from Triton X-114-fractionated T. pallidum cells, suggesting that it is an integral membrane protein. The highly immunogenic nature, membrane location, and pathogen specificity of the 35.5-kDa lipoprotein have prompted our further investigation of this antigen.
MATERIALS AND METHODS
Bacterial strains and growth conditions. T. pallidum Nichols and street strain 14 (43, 44) were cultivated, harvested, and purified as previously described (40, 41, 43) . Escherichia coli HB101 and CC118 (23) Preparation of chromosomal and plasmid DNAs. T. pallidum street strain 14 cells were gradient purified as previously described (4), and high-molecular-weight chromosomal DNA was prepared by the method of Saito and Miura (36) . Plasmid DNA was prepared by the method of Birnboim and Doly (5) . Competent E. coli cells were prepared by the method of Hanahan (17) . Plasmids pHC79 (18) were extracted from infected rabbit testes and intrinsically labeled with Tran35S-label as previously described (40) . Cells of Treponema phagedenis biotype Reiter, Treponema denticola, and Leptospira interrogans were grown and intrinsically radiolabeled as previously described (28, 40) . Borrelia burgdorferi cells were grown in BSK II medium (3) supplemented with 5% NRS and radiolabeled overnight in a modified BSK II medium in which the methionine was deleted from the CMRL supplement. Labeled cells of the different species of spirochetes were washed and then solubilized in TE-SDS, and immunoprecipitations were performed and analyzed as previously described (40) .
[3H]palmitate radiolabeling of E. coli and T. pallidum
lipoproteins. E. coli and T. pallidum cells were labeled with
[3H]palmitate according to the procedure of Swancutt et al. (46) . The labeled cells were washed, solubilized in TE-SDS, and immunoprecipitated as previously described (40) . Cell fractionation studies. Triton X-114 phase partitioning of T. pallidum Nichols was performed by the method of Radolf et al. (33) . Tran35S-labeled organisms (109) were extracted with 0.2% Triton X-114 (detergent-to-protein ratio of 10:1). Detergent-and aqueous-phase proteins were acetone precipitated and resuspended in TE-SDS buffer. Immunoprecipitations were performed and analyzed as previously described (40) .
Processing studies of the 35.5-kDa lipoprotein. For pulsechase studies, E. coli clones were grown in LB containing ampicillin to an optical density at 600 nm of 0.3. A 6-ml volume of each culture was removed, pelleted by centrifu- The chase was initiated by the addition of a 0.1 volume of 4% unlabeled methionine. Samples (0.7 ml) were removed at the indicated times (min) and added to an equal volume of ice-cold 10% trichloroacetic acid, and the precipitates were processed as previously described (12) . Immunoprecipitates of the samples were analyzed by SDS-PAGE with a Tris buffer system as previously described (43) or with a recirculating phosphate buffer system (20) .
For experiments involving the inhibition of processing, E.
coli cells containing pCH1 were grown in LB containing ampicillin to an optical density at 600 nm of 0. 
RESULTS
Identification of recombinant clones expressing T. pallidum protein antigens. A T. pallidum street strain 14 chromosomal DNA library was constructed. Nine hundred fifty clones were grown on LB agar containing ampicillin, transferred to nitrocellulose, and screened for the expression of treponemal antigens. Forty clones tested positive. When these clones were retested to verify the production of treponemal antigens, some of them appeared to lose reactivity, likely because of instability of the recombinant cosmids. The expression of T. pallidum protein antigens by the remaining, confirmed-positive clones was analyzed by immunoprecipitation of solubilized, radiolabeled cell extracts with preabsorbed ERSS. Several clones expressing unique protein profiles were identified by SDS-PAGE analysis of the precipitates.
One of the positive clones, which contained a recombinant cosmid designated pCH1, was chosen for further investigation. This clone was of interest because it expressed a single, strongly antigenic 35.5-kDa protein which appeared as a cone-shaped band by SDS-PAGE, suggesting that it might be lipid modified (Fig. 1, lane F C and F, respectively) . The solubilized E. coli pCH1 extract was also precipitated with ERSS (lane G). precipitated a protein of comparable size from solubilized, radiolabeled cellular extracts of both T. palliduim Nichols and E. coli containing pCH1 (Fig. 3, lanes C and F) . This was the same protein that was originally recognized by ERSS in solubilized, radiolabeled cellular extracts of E. coli containing pCH1. Normal preimmune rabbit serum did not react with the 35.5-kDa protein (Fig. 3, lanes B and E) .
Reactivity of human sera with the recombinant 35. Specificity of the 35.5-kDa protein to T. pallidum. Solubilized, radiolabeled cell extracts of nonpathogenic Treponema species and other pathogenic spirochetes (T. phagedenis biotype Reiter, T. denticola, L. interrogans, and B. burgdorferi) were immunoprecipitated with the rabbit polyclonal anti-35.5-kDa-protein serum. There was no specific reactivity of this antiserum to any of these spirochetal species, indicating that the 35.5-kDa protein is likely specific to pathogenic treponemes (data not shown). It was also of interest to determine whether the 35.5-kDa protein is found in T. pertenue, the causative agent of yaws, since this pathogenic treponeme is very closely related to T. pallidum (24) . Because T. pertenue cells were not available, serum from a rabbit infected with T. pertenue was used to immunoprecipitate solubilized, radiolabeled extracts of E. coli cells containing pCH1. The anti-T. pertenue serum reacted with the recombinant 35.5-kDa protein, indicating that this antigen is common to both T. pallidum and T. pertenue (data not shown).
Membrane localization of the 35.5-kDa protein in native T. pallidum and in E. coli containing pCH1. Tran35S-labeled cells of T. pallidum Nichols were extracted with 0.2% Triton X-114, and the solubilized material was partitioned into detergent and aqueous phases. Although many of the cellular proteins were insoluble in the Triton X-114 or remained present in the aqueous phase, a limited number of proteins were present in the detergent phase, as previously described by Radolf et al. (33) and Cunningham et al. (11) , thus identifying them as integral membrane proteins (Fig. 4, lane  A) . Immunoprecipitation of the various fractions with ERSS revealed the profile of antigenic proteins in each fraction (Fig. 4, the anti-35.5-kDa-protein serum demonstrated that the 35.5-kDa protein is present in both the insoluble material and the detergent phase but is completely absent from the aqueous phase (Fig. 4, lane D for each fraction) . Note that the few proteins precipitated from the aqueous phase by the anti-35.5-kDa-protein serum also were precipitated by the preimmune serum from the same rabbit. However, the preimmune serum did not precipitate any proteins from the detergent phase (data not shown).
Radiolabeled E. coli cells containing cosmid pCH1 were disrupted by sonication and ultracentrifuged to separate the soluble fraction from the whole-membrane pellet as previously described (40) . Immunoprecipitation of the fractions with anti-35.5-kDa-protein serum showed that the majority of the recombinant 35.5-kDa protein is associated with the whole-membrane fraction of E. coli (data not shown).
3H-fatty acid labeling of the 35.5-kDa protein shows it is a lipoprotein. Most of the Triton X-114 DPPs of T. pallidum have been shown to be lipoproteins (8) . To covalent incorporation of the fatty acid into lipid moieties of the proteins rather than degradation of the fatty acids and nonspecific incorporation into amino acids (8, 46) . We also radiolabeled cells of T. pallidum Nichols with [3H]palmitate.
Immunoprecipitation of solubilized extracts of the labeled treponemal cells with anti-35.5-kDa-protein serum confirmed that the native protein is lipid modified (Fig. 5, bottom  panel, lane C) .
Processing of the 35.5-kDa lipoprotein. The lipid modification and the membrane location of the 35.5-kDa lipoprotein suggested that the protein might be made as a highermolecular-mass precursor and then processed to a smaller mature form by signal sequence cleavage during translocation across the cytoplasmic membrane. In pulse-chase studies of E. coli cells containing pCH1, the recombinant 35.5-kDa lipoprotein did not appear to be processed. When immunoprecipitates were visualized by SDS-PAGE and fluorography, the lipoprotein migrated identically at all time points (Fig. 6, panel A) protein, the 39-kDa basic membrane protein, which is known to be processed in E. coli (12) , was labeled in a parallel pulse-chase experiment, and immunoprecipitates were analyzed on the same gel. The 39-kDa basic membrane protein clearly showed processing from a higher-to a lower-molecular-mass form (Fig. 6, panel B) . Immunoprecipitates of solubilized E. coli cells containing pCH1 from the pulsechase experiment also were analyzed by SDS-PAGE with a sodium phosphate buffer system, which has been demonstrated to resolve precursor and mature E. coli Braun lipoprotein (20) . Again, no processing was apparent (data not shown).
Protein export or processing can be inhibited by the exposure of cells to ethanol, sodium azide, or globomycin. Ethanol acts as a membrane perturbant and inhibitor of protein translocation (30) . Sodium azide, at low concentrations, specifically inhibits export of SecA-dependent proteins (29) . Globomycin is known to be an inhibitor of lipoprotein-specific signal peptidase 11 (13) . When E. coli cells containing pCH1 were individually treated with these compounds prior to radiolabeling, the presence of a precursor of the 35.5-kDa lipoprotein with a slightly higher molecular mass was detected after immunoprecipitation of the solubilized cellular extracts (Fig. 7) . These results indicated that the 35.5-kDa lipoprotein is processed from a precursor to a mature form. Failure to detect a precursor form in the pulse-chase experiments must be due to very rapid processing of the 35.5-kDa lipoprotein in E. coli.
Subcloning and restriction mapping of pCH1. Plasmid pCH1 was isolated and digested with the restriction enzyme Hindlll, and the resulting fragments were cloned into the HindIlI site of plasmid pBR328. Subclones were screened by immunoassay with preabsorbed ERSS and an alkaline phosphatase detection system. The gene expressing the 35.5-kDa protein was found to be contained in a 3.8-kb HindlIl fragment of treponemal DNA. This construct was designated pCH2. A restriction map of pCH2 was generated (Fig. 8) .
The following restriction enzymes did not cut within the treponemal DNA insert: BamHI, HpaI, KpnI, NdeI, Sacl, SmaI, and XhoI. A fragment of the pCH2 treponemal insert extending from the StuI site to the left-hand HindlIl site was subcloned into plasmid pBS+ in both orientations, generating plasmids pCH3 and pCH4. The (Fig. 8) . One of the transformants, designated B2, was chosen for further study. Solubilized extracts of Tran35S-labeled cells of B2 were immunoprecipitated with antiserum against the 35.5-kDa lipoprotein or alkaline phosphatase. As seen in Fig. 9 (11) .
Although the partitioning of the native 35.5-kDa lipoprotein into the Triton X-114 detergent phase suggests that it is an integral membrane protein, the precise cellular location of this protein remains in question, as does that of the other T. pallidum DPPs. Some of these proteins, namely the 47-and 34-kDa lipoproteins, were originally reported to be cell surface exposed by a number of criteria that were subsequently found to be somewhat problematic (19, 47) . More recent techniques, such as freeze-fracture and freeze-etch electron microscopy, have suggested that the T. pallidum outer membrane contains a paucity of protein (34, 51 (38) demonstrated that a 42-kDa T. pallidum lipoprotein (TmpA) is also processed from a precursor to a mature form. Globomycin, a selective inhibitor of the lipoprotein-specific signal peptidase II, abolished the processing of the 42-, 34-, and 15-kDa lipoproteins in E. coli (32, 38, 46) . We could not detect processing of the recombinant 35.5-kDa treponemal lipoprotein by pulse-chase studies using standard SDS-PAGE analysis or employing a sodium phosphate buffer system which resolved the precursor and mature forms of the E. coli Braun lipoprotein (20) . However, when we pretreated E. coli cells containing pCH1 with inhibitors of protein processing or export, such as ethanol, sodium azide, or globomycin, we detected a precursor form of the 35.5-kDa lipoprotein. Furthermore, studies of the fusion of the 35.5-kDa lipoprotein to signal sequence-deficient alkaline phosphatase clearly demonstrated that this lipoprotein contains an export signal, presumably a signal sequence, that promotes the extracytoplasmic localization of the hybrid protein. A 47-kDa lipoprotein that has been extensively studied by Chamberlain et al. is an example of a T. pallidum integral membrane protein that, on the basis of the results of pulsechase studies, also does not appear to undergo processing in E. coli (9) . Treatment of T. pallidum cells with globomycin did not reveal a precursor form of this lipoprotein (46) .
Several investigators have reported the identification of clones expressing treponemal protein antigens within the molecular-size range of the 35.5-kDa lipoprotein (1, 26, 43) . Isolation of a clone expressing a 35-kDa T. pallidum Nichols protein (TmpC) that bears some resemblance to the 35.5-kDa protein was reported by van Embden et al. (50) . More recently, Bailey et al. have reported the isolation of a recombinant plasmid (pMJB40) encoding a 29-kDa T. pallidum protein that likely represents a truncated form of the 35-kDa protein, since monoclonal antibody that recognizes this protein also appears to recognize TmpC (1). Unfortunately, the information available for TmpC is incomplete.
TmpC is membrane associated, does not react with antiserum to the nonpathogenic Reiter treponeme, labels with
[3H]palmitate, and has a banding pattern by SDS-PAGE similar to that of the 35.5-kDa lipoprotein that we have characterized (38, 50) . Preliminary sequence data suggest that TmpC has a signal sequence and a signal peptidase II cleavage site (38) . Since a restriction map for the gene encoding TmpC has not been published, we compared our restriction map for pCH2 with that for pMJB40. Substantial differences that are not explained by the truncated nature of the gene exist. For example, pMJB40 lacks two PstI sites found to the left of the central ClaI site in pCH2. Furthermore, pMJB40 contains a PvuII site close to the ClaI site which is absent from pCH2. If these clones contain the same gene, the restriction site differences would likely be due to differences in the DNA sequences of T. pallidum street strain 14 and Nichols.
The development of an effective vaccine to prevent infection with T. pallidum has been a major long-term goal of syphilis researchers. It is hoped that recombinant DNA technology will facilitate this endeavor. However, attempts to immunize animals with recombinant T. pallidum proteins have failed to induce protective immunity (7, 45, 52) . Because of the highly immunogenic nature, membrane location, and pathogen specificity of the 35.5-kDa lipoprotein, we initiated studies to determine the effect of immunization with this antigen on the clinical course of syphilis in the rabbit model. Our preliminary results suggest that immunization with the 35.5-kDa lipoprotein alters the response of rabbits to experimental syphilitic infection (19a) . We think that these observations are of sufficient interest to warrant further investigation. Studies are currently under way in our laboratories to sequence the gene encoding the 35.5-kDa T.
pallidum lipoprotein. Analysis of the DNA sequence should provide further insight into the processing and maturation of this pathogen-specific antigen. Additionally, such information will likely prove useful in the development of strategies to enhance the expression of the recombinant 35.5-kDa lipoprotein in E. coli, thus facilitating purification and further characterization of its vaccinogenic or diagnostic potential.
